Seattle, WA, United States of America

Lucien Barnes, V

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Access to Advanced Health Institute. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lucien Barnes, V. Retrieved from https://idiyas.com/inventor/lucien-barnes-v-cq1d1ni4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lucien Barnes, V: Innovator in Vaccine Formulations

Introduction

Lucien Barnes, V is a notable inventor based in Seattle, WA. He has made significant contributions to the field of vaccine development. His innovative work focuses on creating more effective vaccine formulations.

Latest Patents

Lucien holds a patent for "Single Vial Vaccine Formulations." This patent represents his commitment to improving healthcare solutions through innovative approaches to vaccine delivery.

Career Highlights

Lucien is currently associated with Access to Advanced Health Institute. His role at the institute allows him to work on groundbreaking research and development in the health sector. With a patent portfolio that includes 1 patent, he continues to push the boundaries of medical science.

Collaborations

Lucien collaborates with Christopher B. Fox, enhancing the research efforts at Access to Advanced Health Institute. Their combined expertise fosters an environment of innovation and discovery.

Conclusion

Lucien Barnes, V exemplifies the spirit of innovation in the healthcare industry. His work on vaccine formulations is paving the way for advancements in public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…